Aging Clinical and Experimental Research

, Volume 5, Issue 2, pp 81–93

Osteoporosis: Assessment of bone loss and remodeling

  • Joan A. McGowan
Review Article

Abstract

Osteoporosis, the most common metabolic bone disorder, is a major health problem in older individuals, and especially in postmenopausal women throughout the world. It is characterized by low bone mass, structural deterioration, and an increased risk of fracture. The expected growth in the percentage of the world population over 65 years of age suggests that control of the chronic diseases of the elderly must be a major international priority. In order to design and implement appropriate prevention and treatment strategies for osteoporosis, it is necessary to assess the extent of the disease or condition in populations, and in individuals in a clinical setting. This review focuses on available and emerging techniques to measure bone mass or density, and on the role of biochemical markers of bone remodeling in the prediction of future bone loss. In order to prevent a disease that progresses without any obvious symptoms, it is important to determine not only the current status of bone mass and remodeling but also to develop methods to predict future bone loss. Different information is derived from each of the assessment approaches, and a combination of measures may be necessary to develop accurate predictive models. (Aging Clin. Exp. Res. 5: 81-93, 1993)

Keywords

Biomarkers densitometry osteoporosis remodeling 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Consensus development conference: Prophylaxis and treatment of osteoporosis. Am. J. Med. 90: 107–110, 1991.CrossRefGoogle Scholar
  2. 2.
    Consensus conference: Osteoporosis. JAMA 252: 799–802, 1984.CrossRefGoogle Scholar
  3. 3.
    Peck W.A., Riggs B.L., Bell N.H., Wallace R.B., Johnston C.C. Jr., Gordon S.L., Shulman L.E.: Research directions in osteoporosis. Am. J. Med. 84: 275–282, 1988.PubMedCrossRefGoogle Scholar
  4. 4.
    Christiansen C., Arnaud C., Nordin B., Parfitt A.M., Peck W.A., Riggs B.L.: Osteoporosis: Proceedings of the Copenhagen International Symposium on Osteoporosis. Glostrup Hospital, Copenhagen, 1984.Google Scholar
  5. 5.
    Christiansen C., Johansen J.S., Riis B.J.: Osteoporosis 1987. Osteopress ApS, Copenhagen, 1987.Google Scholar
  6. 6.
    Christiansen C., Overgaard K.: Osteoporosis 1990. Osteopress ApS, Copenhagen, 1990.Google Scholar
  7. 7.
    Maggi S., Kelsey J.L., Litvak J., Heyse S.P.: Incidence of hip fractures in the elderly: a cross-national analysis. Osteoporos. Int. 1: 232–241, 1991.PubMedCrossRefGoogle Scholar
  8. 8.
    Kelsey J.L.: Risk factors for osteoporosis and associated fractures. Public Health Rep. 104 (Suppl): 14–20, 1989.PubMedGoogle Scholar
  9. 9.
    Genant H.K., Block J.E., Steiger P., Gluer C.C., Ettinger B., Harris S.T.: Appropriate use of bone densitometry. Radiology 170: 817–822, 1989.PubMedGoogle Scholar
  10. 10.
    Melton L.J., Eddy D.M., Johnston C.C. Jr.: Screening for osteoporosis. Ann. Intern. Med. 112: 516–528, 1990.PubMedCrossRefGoogle Scholar
  11. 11.
    Melton L.J. III, Kan S.H., Wahner H.W., Riggs B.L.: Lifetime fracture risk: An approach to hip fracture risk assessment based on bone mineral density and age. J. Clin. Epidemiol. 41: 985–994, 1988.PubMedCrossRefGoogle Scholar
  12. 12.
    Black D.M., Cummings S.R., Melton L.J.: Appendicular bone mineral and a woman’s lifetime risk of hip fracture. J. Bone Miner. Res. 7: 639–646, 1992.PubMedCrossRefGoogle Scholar
  13. 13.
    Delmas P.: Biochemical Markers of Bone Turnover in Osteoporosis. In: Riggs B.L., Melton L.J. III (Eds.), Osteoporosis: Etiology, Diagnosis, and Management. Raven Press, New York, 1988, pp. 297–316.Google Scholar
  14. 14.
    Delmas P.: Biochemical markers of bone turnover for the clinical assessment of metabolic bone disease. Endocrinol. Metab. Clin. North Am. 19: 1–18, 1990.PubMedGoogle Scholar
  15. 15.
    Silverberg S.: The Distribution and Balance of Calcium, Magnesium and Phosphorus. In: Favus M. (Ed.), Primer on the Metabolic Bone. Diseases and Disorders of Mineral Metabolism. American Society for Bone and Mineral Research, Kelseyville, 1990, pp. 30–32.Google Scholar
  16. 16.
    Raisz L.G.: Recent advances in bone cell biology: interactions of vitamin D with other local and systemic factors. Bone Miner. 9: 191–197, 1990.PubMedCrossRefGoogle Scholar
  17. 17.
    Canalis E., McCarthy T.L., Centrella M.: Growth factors and cytokines in bone cell metabolism. Annu. Rev. Med. 42: 17–24, 1991.PubMedCrossRefGoogle Scholar
  18. 18.
    Mundy G.R.: Local Factors Regulating Osteoclast Function. In: Rifkin B.R., Gay C.V. (Eds.), The Biology and Physiology of the Osteoclast. CRC Press, 1992, pp. 1-27.Google Scholar
  19. 19.
    Parfitt A.M.: Bone Remodeling: Relationship to the Amount and Structure of Bone, and the Pathogenesis and Prevention of Fractures. In: Riggs B.L., Melton L.J. III (Eds.), Osteoporosis: Etiology, Diagnosis, and Management. Raven Press, New York, 1988, pp. 45–93.Google Scholar
  20. 20.
    Parfitt A.M.: The Three Organizational Levels of Bone Remodeling: Implications for the Interpretation of Biochemical Markers and the Mechanisms of Bone Loss. In: Christiansen C., Overgaard K. (Eds.), Osteoporosis 1990. Osteopress ApS, Copenhagen, 1990, pp. 429–434.Google Scholar
  21. 21.
    Kahn A.J., Fallon M.D., Teitelbaum S.F.: Structure-function Relationships in Bone: An Examination of Events at the Cellular Level. In: Peck W. (Ed.), Bone and Mineral Research 2. Elsevier, Amsterdam, 1984, pp. 125–174.Google Scholar
  22. 22.
    Teitelbaum S.: Skeletal Growth and Development. In: Favus M. (Ed.), Primer on the Metabolic Bone diseases and Disorders of Mineral Metabolism. American Society for Bone and Mineral Research, Kelseyville, 1990, pp. 7–11.Google Scholar
  23. 23.
    Riggs B.L.: Overview of Osteoporosis. In: Smith L.H. (Ed.), Cecil Textbook of Medicine. Key Pharmaceuticals Kenilworth, N.J., 1992, pp. 27–40.Google Scholar
  24. 24.
    Cummings S.R., Black D.M., Nevitt M.C., Browner W.S., Cauley J.A., Genant H.K., Mascioli S.R., Scott J.C., Seeley D.G., Steiger P., Vogt T.M.: Appendicular bone density and age predict hip fracture in women. JAMA 263: 665–709, 1990.PubMedCrossRefGoogle Scholar
  25. 25.
    Hui S.L., Slemenda C.W., Johnston C.C. Jr.: Age and bone mass as predictors of fracture in a prospective study. J. Clin. Invest. 81: 1804–1809, 1988.PubMedCrossRefGoogle Scholar
  26. 26.
    Lukert B.P., Raisz L.G.: Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann. Intern. Med. 112: 352–364, 1990.PubMedCrossRefGoogle Scholar
  27. 27.
    Stall G.M., Harris S., Sokoll L.J., Dawson-Hughes B.: Accelerated bone loss in hypothyroid patients overtreated with L-thyroxine. Ann. Intern. Med. 113: 265–269, 1990.PubMedCrossRefGoogle Scholar
  28. 28.
    Lindsay R.: Sex Steroids in the Pathogenesis and Prevention of Osteoporosis. In: Riggs B.L., Melton L.J. III (Eds.), Osteoporosis: Etiology, Diagnosis and Management. Raven Press, New York, 1988, pp. 333–358.Google Scholar
  29. 29.
    Frost H.M.: Skeletal structural adaptations to mechanical usage (SATMU): I. Redefining Wolff’s law: the bone modeling problem. Anat. Rec. 226: 403–413, 1990.Google Scholar
  30. 30.
    Frost H.M.: Skeletal structural adaptations to mechanical usage (SATMU): II. Redefining Wolff’s law: the remodeling problem. Anat. Rec. 226: 414–422, 1990.CrossRefGoogle Scholar
  31. 31.
    Slemenda C.W., Christian J.C., Williams C.J., Norton J.A., Johnston C.C. Jr.: Genetic determinants of bone mass in adult women: a reevaluation of the twin model and the potential importance of gene interaction on heritability estimates. J. Bone Miner. Res. 6: 561–567, 1991.PubMedCrossRefGoogle Scholar
  32. 32.
    Kelly P.J., Hopper J.L., Macaskill G.T., Pocock N.A., Sambrook P.N., Eisman J.A.: Genetic factors in bone turnover. J. Clin. Endocrinol. Metab. 72: 808–813, 1991.PubMedCrossRefGoogle Scholar
  33. 33.
    Matkovic V., Fontana D., Tominac C., Goel P., Chesnut C.H. III: Factors that influence peak bone mass formation: A study of calcium balance and the inheritance of bone mass in adolescent females. Am. J. Clin. Nutr. 52: 878–888, 1990.PubMedGoogle Scholar
  34. 34.
    Heaney R.P., Recker R.R., Stegman M.R., Moy A.J.: Calcium absorption in women: Relationships to calcium intake, estrogen status, and age. J. Bone Miner. Res. 4: 469–475, 1989.PubMedCrossRefGoogle Scholar
  35. 35.
    Heaney R.P.: Nutritional Factors in Bone Health. In: Riggs B.L., Melton L.J. III (Eds.), Osteoporosis: Etiology, Diagnosis and Management. Raven Press, New York, 1988, pp. 359–388.Google Scholar
  36. 36.
    Johnston C.C., Miller J.Z., Slemenda C.W., Reister T.K., Hui S., Christian J.C., Peacock M.: Calcium supplementation and increases in bone mineral density in children. N. Engl. J. Med. 327: 82–87, 1992.PubMedCrossRefGoogle Scholar
  37. 37.
    Nordin B.E., Need A.G., Bridges A., Horowitz M.: Relative contributions of years since menopause, age, and weight to vertebral density in postmenopausal women. J. Clin. Endocrinol. Metab. 74: 20–23, 1992.PubMedCrossRefGoogle Scholar
  38. 38.
    Farmer M.E., Harris T., Madans J.H., Wallace R.B., Cornoni-Huntley J., White L.R.: Anthropometric indicators and hip fracture. The NHANES I epidemiologic follow-up study. J. Am. Geriatr. Soc. 37: 9–16, 1989.Google Scholar
  39. 39.
    Slemenda C.W., Hui S.L., Longcope C., Johnston C.C. Jr.: Cigarette smoking, obesity, and bone mass. J. Bone Miner. Res. 4: 737–741, 1989.PubMedCrossRefGoogle Scholar
  40. 40.
    Davies M.C., Hall M.L., Jacobs H.S.: Bone mineral loss in young women with amenorrhea. Br. Med. J. 301: 790–793, 1990.CrossRefGoogle Scholar
  41. 41.
    Prior J.C., Vigna Y.M., Schechter M.T., Burgess A.E.: Spinal bone loss and ovulatory disturbances. N. Engl. J. Med. 323: 1221–1227, 1990.PubMedCrossRefGoogle Scholar
  42. 42.
    Lindsay R., Cosman F.: Estrogen in prevention and treatment of osteoporosis. Ann. N.Y. Acad. Sci. 592: 326–333, 1990.PubMedCrossRefGoogle Scholar
  43. 43.
    Lindsay R.: Estrogens, bone mass, and osteoporotic fracture. Am. J. Med. 91: 10S–13S, 1991.PubMedCrossRefGoogle Scholar
  44. 44.
    Barrett-Connor E.: The RDA for calcium in the elderly: too little, too late. Calcif. Tissue Int. 44: 303- 307, 1989.PubMedCrossRefGoogle Scholar
  45. 45.
    Dawson-Hughes B., Dallai G.E., Krall E.A., Sadowski L., Sahyoun N., Tannenbaum S.: A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N. Engl. J. Med. 323: 878–883, 1990.PubMedCrossRefGoogle Scholar
  46. 46.
    Smith E.L., Gilligan C: Physical activity effects on bone metabolism. Calcif. Tissue Int. 49: 50–54, 1991.CrossRefGoogle Scholar
  47. 47.
    Prince R.L., Smith M., Dick I.M., Price R.I., Webb P.G., Henderson N.K., Harris M.M.: Prevention of postmenopausal osteoporosis. A comparative study of exercise, calcium supplementation, and hormone-replacement therapy. N. Engl. J. Med. 325: 1189–1195, 1991.PubMedCrossRefGoogle Scholar
  48. 48.
    Dawson-Hughes B.: Calcium supplementation and bone loss: a review of controlled clinical trials. Am. J. Clin. Nutr. 54: 274S–280S, 1991.PubMedGoogle Scholar
  49. 49.
    Steiger P., Cummings S.R., Black D.M., Spenser N.E., Genant H.K.: Age-related decrements in bone mineral density in women over 65. J. Bone Miner. Res. 7: 625–632, 1992.PubMedCrossRefGoogle Scholar
  50. 50.
    Cummings S.R., Browner W.S., Grady D., Ettinger B.: Should prescription of postmenopausal hormone therapy be based on the results of bone densitometry? Ann. Intern. Med. 113: 565–567, 1990.CrossRefGoogle Scholar
  51. 51.
    Cummings S.R., Rubin S.M., Black D.: The future of hip fractures in the United States. Numbers, costs, and potential effects of postmenopausal estrogen. Clin. Orthop. 252: 163–166, 1990.Google Scholar
  52. 52.
    Tosteson A.N., Rosenthal D.I., Melton L.J. III, Weinstein M.C.: Cost effectiveness of screening perimenopausal white women for osteoporosis: bone densitometry and hormone replacement therapy. Ann. Intern. Med. 113: 594–603, 1990.PubMedCrossRefGoogle Scholar
  53. 53.
    Ross P.D., Davis J.W., Vogel J.M., Wasnich R.D.: A critical review of bone mass and the risk of fractures in osteoporosis. Calcif. Tissue Int. 46: 149–161, 1990.PubMedCrossRefGoogle Scholar
  54. 54.
    Black D.M., Cummings S.R., Genant H.K., Nevitt M.C., Palermo L., Browner W.: Axial and appendicular bone density predict fractures in older women. J. Bone Miner. Res. 7: 633–638, 1992.PubMedCrossRefGoogle Scholar
  55. 55.
    Johnston C,C. Jr., Slemenda C.W., Melton L.J.: Clinical use of bone densitometry. N. Engl. J. Med. 324: 1105–1109, 1991.PubMedCrossRefGoogle Scholar
  56. 56.
    Melton L.J. III, Eddy D.M., Johnston C.C.: Screening for osteoporosis. Ann. Intern. Med. 112: 516–528, 1990.PubMedCrossRefGoogle Scholar
  57. 57.
    Johnston C.C. Jr., Slemenda C.W.: Non-invasive methods for quantitating bone loss of aging. Exp. Gerontol. 25: 297–301, 1990.PubMedCrossRefGoogle Scholar
  58. 58.
    Johnson J., Dawson-Hughes B.: Precision and stability of dual-energy X-ray absorptiometry measurements. Calcif. Tissue Int. 49:174–178, 1991.PubMedCrossRefGoogle Scholar
  59. 59.
    Genant H.K., Faulkner K.G., Gluer C.C.: Measurement of bone mineral density: current status. Am. J. Med. 91: 49S–53S, 1991.PubMedCrossRefGoogle Scholar
  60. 60.
    Faulkner K.G., Gluer C.C., Majumdar S., Lang P., Engelke K., Genant H.K.: Noninvasive measurements of bone mass, structure, and strength: current methods and experimental techniques. Am. J. Roentgenol. 157: 1229–1237, 1991.CrossRefGoogle Scholar
  61. 61.
    Seeley D.G., Browner W.S., Nevitt M.C., Genant H.K., Scott J.C., Cummings S.R.: Which fractures are associated with low appendicular bone mass in elderly women? Ann. Intern. Med. 115: 837–842, 1991.CrossRefGoogle Scholar
  62. 62.
    Ross P.D., Davis J.W., Epstein R.S., Wasnich R.D.: Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann. Intern. Med. 114: 919–923, 1991.PubMedCrossRefGoogle Scholar
  63. 63.
    Cummings S.R., Black D.M., Nevitt M.C., Browner W.S., Cauley J.A., Genant H.K., Mascioli S.R., Scott J.C., Seeley D.G., Steiger P.: Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group. JAMA 263: 665–668, 1990.Google Scholar
  64. 64.
    Eastell R., Wahner H.W., O’Fallon W.M., Amadio P.C., Melton L.J., Riggs B.L.: Unequal decrease in bone density of lumbar spine and ultradistal radius in Colles’ and vertebral fracture syndromes. J. Clin. Invest. 83: 168–174, 1989.PubMedCrossRefGoogle Scholar
  65. 65.
    Epstein S.: Serum and urinary markers of bone remodeling: assessment of bone turnover. Endocr. Rev. 9:437–449, 1988.PubMedCrossRefGoogle Scholar
  66. 66.
    Delmas P.D.: Biochemical markers of bone turnover: methodology and clinical use in osteoporosis. Am. J. Med. 91: 59S–63S, 1991.PubMedCrossRefGoogle Scholar
  67. 67.
    Mazzuoli G., Minisola S., Valtorta R.: Changes in mineral content and biochemical bone markers at the menopause. Isr. J. Med. Sci. 21: 875–877, 1985.PubMedGoogle Scholar
  68. 68.
    Stepan J., Pospichal J., Presl J., Pacvsky V.: Bone loss and biochemical indices of bone remodeling in surgically induced post-menopausal women. Bone 8: 279–284, 1987.PubMedCrossRefGoogle Scholar
  69. 69.
    Kraenzlin M., Taylor A., Baylink D.: Biochemical Markers for Bone Formation and Resorption. In: Lindh E., Thoreil J. (Eds.), Clinical Impact of Bone and Connective Tissue Markers. Academic Press, Boston, 1989, pp. 289–303.CrossRefGoogle Scholar
  70. 70.
    Eyre D.: Collagen cross-linking amino acids. Methods Enzymol. 144: 115–139, 1987.PubMedCrossRefGoogle Scholar
  71. 71.
    Eyre D.R., Koob T.J., Van Ness K.P.: Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatography. Anal. Biochem. 137: 380–388, 1984.PubMedCrossRefGoogle Scholar
  72. 72.
    Hanson D., Eyre D.: A specific immunoassay for bone resorption based on cross-linked collagen peptides in urine. J. Bone Miner. Res. 6: s251, 1991.Google Scholar
  73. 73.
    Risteli J., Niemi S., Elomaa I., Risteli L.: Bone resorption assay based on a peptide liberated during type 1 collagen degradation. J. Bone Miner. Res. 6: s251, 1991.Google Scholar
  74. 74.
    Lau W., Onishi T., Wergedal J.: Characterization of an assay for human serum Tartrate-Resistant Acid Phosphatase activity: A potential assay to assess bone resorption. Clin. Chem. 33: 458–462, 1987.PubMedGoogle Scholar
  75. 75.
    Allen S., Nuttleman P., Ketchan R., Roberts R.: Purification and characterization of human bone Tartrate-Resistant Acid Phosphatase. J. Bone Miner. Res. 4: 47–55, 1989.PubMedCrossRefGoogle Scholar
  76. 76.
    Parfitt A., Simon L., Villanueva A., Krane S.: Procollagen Type I Carboxy-terminal extensions peptide in serum as a marker of collagen biosynthesis in bone: Correlation with iliac bone formation rates and comparison with total alkaline phosphatase. J. Bone Miner. Res. 2: 427–436, 1987.PubMedCrossRefGoogle Scholar
  77. 77.
    Farley J., Hall S., Ritchie C., Herring S., Orcutt C., Miller B.: Quantitation of skeletal phosphatase isozyme activity in canine serum. J. Bone Miner. Res. 7: 779–792, 1992.PubMedCrossRefGoogle Scholar
  78. 78.
    Hauschka P., Lian J., Cole D., Gundberg C: Osteocalcin and related Ca2+-binding proteins in bone. Physiol. Rev. 69: 990–1047, 1989.PubMedGoogle Scholar
  79. 79.
    Lian J., Gundberg C.: Osteocalcin: Biochemical considerations and clinical applications. Clin. Orthop. Res. 226: 267–291, 1988.Google Scholar
  80. 80.
    Price P.A.: Gla-containing proteins of bone. Connect. Tissue Res. 21:51–57, 1989.CrossRefGoogle Scholar
  81. 81.
    Riggs B.L., Tsai K.S., Mann K.G.: Effect of acute increases in bone matrix degradation on circulating levels of bone-Gla protein. J. Bone Miner. Res. 1: 539–542, 1986.PubMedCrossRefGoogle Scholar
  82. 82.
    Delmas P.D., Christiansen C., Mann K.G., Price P.A.: Bone Gla protein (osteocalcin) assay standardization report. J. Bone Miner. Res. 5: 5–11, 1990.PubMedCrossRefGoogle Scholar
  83. 83.
    Ebeling P.R., Peterson J.M., Riggs B.L.: Utility of type I procollagen propeptide assays for assessing abnormalities in metabolic bone diseases. J. Bone Miner. Res. 7: 1243–1250, 1992.PubMedCrossRefGoogle Scholar
  84. 84.
    Brown J.P., Delmas P.D., Arlot M., Meunier P.J.: Active bone turnover of the cortico-endosteal envelope in postmenopausal osteoporosis. J. Clin. Endocrinol. Metab. 64: 954–959, 1987.PubMedCrossRefGoogle Scholar
  85. 85.
    Eastell R., Delmas P.D., Hodgson S.F., Eriksen E.F., Mann K.G., Riggs B.L.: Bone formation rate in older normal women: concurrent assessment with bone histomorphometry, calcium kinetics, and biochemical markers. J. Clin. Endocrinol. Metab. 67: 741–748, 1988.PubMedCrossRefGoogle Scholar
  86. 86.
    Lufkin E.G., Wahner H.W., O’fallon W.M., Hodgson S.F., Kotowicz M.A., Lane A.W., Judd H.L., Caplan R.H., Riggs B.L.: Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann. Intern. Med. 117: 1–9, 1992.PubMedCrossRefGoogle Scholar
  87. 87.
    Delmas P.D., Stenner D., Wahner H.W., Mann K.G., Riggs B.L.: Increase in serum bone gamma-carboxyglutamic acid protein with aging in women. Implications for the mechanism of age-related bone loss. J. Clin. Invest. 71: 1316–1321, 1983.Google Scholar
  88. 88.
    Johansen J.S., Riis B.J., Delmas P.D., Christiansen C.: Plasma BGP: an indicator of spontaneous bone loss and of the effect of oestrogen treatment in postmenopausal women. Eur.J. Clin. Invest. 18: 191–195, 1988.PubMedCrossRefGoogle Scholar
  89. 89.
    Uebelhart D., Schlemmer A., Johansen J.: Effect of menopause and hormone replacement therapy on urinary excretion of pyridinium crosslinks. J. Clin. Endocrinol. Metab. 72: 367–373, 1991.PubMedCrossRefGoogle Scholar
  90. 90.
    Eastell R., Colwell A., Assiri A.: Prediction of response in estrogen therapy using deoxypyridinoline. J. Bone Miner. Res. 5: 1990.Google Scholar
  91. 91.
    Eastell R., Hampton L., Colwell A.: Urinary collagen crosslinks are highly correlated with radioisotopic measurements of bone resorption. Third International Symposium on Osteoporosis, 1990, pp. 469-470 (Abstract).Google Scholar
  92. 92.
    Uebelhart D., Gineyts M., Chapuy M., Delmas P.: Urinary excretion of pyridinium crosslinks: A new marker of bone resorption in metabolic bone disease. Bone Miner. 8: 87–96, 1992.CrossRefGoogle Scholar
  93. 93.
    Hanson M.A., Overgaard K., Riis B.J., Christiansen C.: Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12-year study. Br. Med. J. 303: 961–964, 1991.CrossRefGoogle Scholar
  94. 94.
    Hui S.L., Slemenda C.W., Johnston C.C. Jr.: The contribution of bone loss to postmenopausal osteoporosis. Osteoporos. Int. 1: 30–34, 1990.PubMedCrossRefGoogle Scholar
  95. 95.
    Schneider E.L., Guralnik J.M.: The aging of America. Impact on health care costs. JAMA 263: 2335–2340, 1990.Google Scholar
  96. 96.
    Osteoporosis Research, Education and Health Promotion, NIH Publication No. 91-3216, Bethesda, 1991.Google Scholar

Copyright information

© Editrice Kurtis s.r.l. 1993

Authors and Affiliations

  • Joan A. McGowan
    • 1
  1. 1.Bone Biology and Bone Diseases BranchNational Institute of Arthritis, Musculoskeletal and Skin DiseasesBethesdaUSA

Personalised recommendations